tirzepatide libido sexual function study 🚨 New Research Alert! 🚨 From @sexmedresearch For the first time, a GLP-1/GIP medication (tirzepatide) has been shown to successfully treat Persistent Genital Arousal Disorder (PGAD/GPD) — a rare, painful, and often Are Sexual Side Effects Emerging

In one 2022 study, patients who stopped taking semaglutide had regained two-thirds of the weight they initially lost one year out.

"Our decision to prefer Wegovy over Zepbound will deliver significant cost savings for our clients in this therapy class, and the lower net price we were able to negotiate for Wegovy will enable more employers to provide coverage for the weight loss category," CVS Health Vice President of External Affairs David Whitrap told IndyStar in a written statement

Both types of medications are tools that, when used in conjunction with lifestyle changes such as diet and exercise, can provide additional support in your weight loss journey

GLP-1 Weight Loss Plateau: Causes & Fixes You started GLP-1 treatment , the weight came off steadily for a few months, and then it didnt

Serious side effects like pancreatitis or thyroid changes are rare and monitored by your healthcare provider during treatment

doi: 10.1111/dom.15269 [DOI] [PubMed] [Google Scholar] 37